HCP Live
Nuerology Live
Contagion Live
OncLive
Neurology Live
Neurology Live
Spotlight
Clinical Focus
Video Series
Media
Conferences
Partners
Resources
Subscribe
  • Advertise
  • Contact Us
  • Editorial
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy

© 2021 MJH Life Sciences and Neurology Live. All rights reserved.

Spotlight
  • AES 2020
Clinical FocusSee All >
  • Dementia/Alzheimer
  • Epilepsy
  • Headache/Migraine
  • Movement Disorders
  • Multiple Sclerosis
  • Neuromuscular
  • Sleep Medicine
  • Stroke
Video Series
  • Cure Connections
  • Insights
  • News Network
  • Peer Exchange
  • Advertise
  • Contact Us
  • Editorial
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.

Management of Narcolepsy and Excessive Daytime Sleepiness

Overview of Excessive Daytime Sleepiness

Overview of Narcolepsy

Signs and Symptoms of Narcolepsy

Narcolepsy Type 1 and Type 2

Diagnosis of Narcolepsy

Goals of Therapy in Narcolepsy

Nonpharmacologic Therapies for Narcolepsy

Laboratory Testing in Patients with Narcolepsy

Traditional Treatments for Narcolepsy

Pitolisant: Recently FDA Approved for Narcolepsy

Solriamfetol: Recently FDA Approved for Narcolepsy

Deciding Which Drug to Use in Narcolepsy

Insurance Coverage For Drugs to Treat Narcolepsy

Patient Resources Including the Narcolepsy Network

Drugs in Development for Treatment of Narcolepsy

Unmet Needs in the Treatment of Narcolepsy

Advice for Community Physicians Treating Narcolepsy

Referral to a Sleep Specialist to Treat Narcolepsy

Final Thoughts on Treating Narcolepsy